Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-22-004771

Options or other derivatives

  • Chief Executive Officer acquired 165,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Seehra Jasbir · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-21 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +165,000 165,000 D
Loading xslF345X03/doc4.xml…